047920.KS · HLB제약
South Korea · RS rating 37 · As of 2026-10-14
| Price | 11,280.00 KRW |
|---|---|
| 1-day change | -6.6% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 98 / 22 / 41 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 42 / 15 / 35 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -109.1% |
| Sales growth Q/Q | -5.1% |
| Distance from 52-week high | +46.0% |
| Market cap (USD) | $426.0M |